| Safe and secure, Microhealth can track your treatment details using your smartphone. |
View online |
|
|
|
| Looking for a reliable way to keep track of your bleeds? |
| If you or someone you care for lives with hemophilia, managing the treatment details can get complicated. But here’s good news: with the Microhealth app, it’s easy to keep track of those details using your mobile device. |
|
|
| The Microhealth app is available for use with any drug product. |
|
|
|
| Microhealth allows you to log infusions and bleeds, set reminders, monitor a loved one’s treatment and send updates to your care team. It’s a safe, secure app for managing the specific details of your treatment and sharing them with your doctor. |
 |
| 1. Record |
| • |
Log bleeds and skipped doses, track infusions, upload photos — and more |
|
|
|
|
 |
| 2. Monitor |
| • |
Get reminders for prophylaxis infusions |
|
| • |
Monitor factor inventory levels |
|
|
|
|
 |
| 3. Connect |
| • |
Share treatment history with your care team |
|
| • |
Send infusion and logging prompts to family members |
|
|
|
|
|
| The Microhealth app was developed to empower you and your loved ones to document the details of your bleeding disorder and share them with your doctor. Novo Nordisk is proud to support Microhealth in an effort to better serve you. |
|
|
| Do you have questions about hemophilia? |
| Living with a bleeding disorder can bring unexpected challenges. Novo Nordisk’s Rare Blood Community Liaisons (RBCL) are active experts in the hemophilia community, offering disease and lifestyle education, tools to help you manage your bleeding disorder, and additional one-on-one support. |
|
|
|
|
| Please do not respond to this email. If you would like to contact us, please click here or call 1‑800-727-6500. |
|
| Novo Nordisk, Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A. |
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
© 2024 Novo Nordisk All rights reserved. US23HRBD00132 September 2024 |
|
 |
|
|
|
